Advanced Enzyme Technologies · NSE: ADVENZYMES · BSE: 540025

Q1 FY27 results · Apr–Jun 2026

Advanced Enzyme Technologies reported revenue from operations of ₹189.79 crore (up 2.1% from Q1 FY26) and net profit of ₹38.59 crore (down 4.6% from Q1 FY26) for Q1 FY27 (Apr–Jun 2026), on a consolidated basis.

Consolidated · ₹ crore
ItemQ1 FY27Q1 FY26YoYQ4 FY26QoQ
Revenue from operations189.79185.91+2.1%203.37−6.7%
Other income13.028.85+47.1%7.23+80.1%
Total income202.81194.76+4.1%210.59−3.7%
Profit before tax53.5354.90−2.5%59.80−10.5%
Net profit for the period38.5940.44−4.6%45.25−14.7%
Attributable to shareholders of the company37.0939.93−7.1%42.96−13.7%
EPS, basic (₹)3.313.57−7.3%3.84−13.8%
Net margin (%)20.321.822.3
Standalone · ₹ crore
ItemQ1 FY27Q1 FY26YoYQ4 FY26QoQ
Revenue from operations115.86125.02−7.3%116.41−0.5%
Other income2.2953.85−95.8%5.16−55.7%
Total income118.14178.88−34.0%121.57−2.8%
Profit before tax29.7481.40−63.5%28.84+3.1%
Net profit for the period22.3573.98−69.8%22.30+0.2%
EPS, basic (₹)2.006.61−69.7%1.99+0.5%
Net margin (%)19.359.219.2
Consolidated
Filed with BSE
08 Aug 2026, 17:38 IST
Board meeting
08 Aug 2026
Period
01 Apr 2026 to 30 Jun 2026
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
08 Aug 2026, 17:38 IST
Board meeting
08 Aug 2026
Period
01 Apr 2026 to 30 Jun 2026
Review status
Unaudited
Source
XBRL filing on BSE